C75 vs C7A.0
C75 (Malignant neoplasm of other endocrine glands and related structures) compared with C7A.0 (Malignant carcinoid tumors), from the official CMS tabular data. Do not report these codes together: the official tabular list marks them Excludes1.
Can these codes be reported together?
No — do not report together. C75 carries an Excludes1 note covering C7A.0: “malignant carcinoid tumors (C7A.0-)”
Sole exception: when the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
No — do not report together. C75 carries an Excludes1 note covering C7A.0: “malignant neuroendocrine tumors (C7A.-)”
Sole exception: when the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
Side by side
| C75Malignant neoplasm of other endocrine glands and related structures | C7A.0Malignant carcinoid tumors | |
|---|---|---|
| Billing status | Non-billable header | Non-billable header |
| Classification | C00-D49 — Neoplasms (C00-D49) | C00-D49 — Neoplasms (C00-D49) |
| Definition | Malignant neoplasm of other endocrine glands and related structures is a non-billable ICD-10-CM category code (C75). | Malignant carcinoid tumors is a non-billable ICD-10-CM category code (C7A.0). |
| Use additional code | — | code to identify any associated endocrine syndrome, such as: carcinoid syndrome (E34.00) |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources